Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIAsk in your own words. Each question is answered independently.
Select a question to fill the editor, then ask it or make it your own.
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| antibiotics, produced by Streptomyces strains | 4028 | 11006-76-1 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
An antibiotic complex originally isolated from Streptomyces mitakaenis. It contains two principle ingredients: STREPTOGRAMIN A (mikamycin A) and STREPTOGRAMIN B (mikamycin B).
|
None
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | D06AX10 | DERMATOLOGICALS ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE ANTIBIOTICS FOR TOPICAL USE Other antibiotics for topical use |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000900 | Anti-Bacterial Agents |
| MeSH PA | D004791 | Enzyme Inhibitors |
| MeSH PA | D011500 | Protein Synthesis Inhibitors |
| CHEBI has role | CHEBI:36047 | antibacterial drug |
| CHEBI has role | CHEBI:76969 | bacterial metabolite |
| CHEBI has role | CHEBI:33282 | antibacterial agent |
None
| Species | Use | Relation |
|---|---|---|
| Cattle | To reduce incidence of liver abscesses | Indication |
| Chickens | To prevent necrotic enteritis caused by Clostridium perfringens | Indication |
| Swine | Dysentery | Indication |
| Product | Applicant | Ingredients |
|---|---|---|
| Stafac 500, Stafac 10, Stafac 20, Stafac 50 | Phibro Animal Health Corp. | 1 |
| V-Max, V-Max 50 | Phibro Animal Health Corp. | 1 |
| Aviax and Stafac | Phibro Animal Health Corp. | 2 |
| Aviax II plus Stafac | Phibro Animal Health Corp. | 2 |
| Stafac and Coban | Phibro Animal Health Corp. | 2 |
| Stafac and Bio-Cox | Phibro Animal Health Corp. | 2 |
| Stafac and AMPROL | Phibro Animal Health Corp. | 2 |
| Stafac and Avatec | Phibro Animal Health Corp. | 2 |
| Clinacox and Stafac | Elanco US Inc. | 2 |
None
None
None
None
| ID | Source |
|---|---|
| N0000007792 | NUI |
| D06311 | KEGG_DRUG |
| C0042754 | UMLSCUI |
| CHEBI:87209 | CHEBI |
| CHEMBL5314345 | ChEMBL_ID |
| CHEMBL5314344 | ChEMBL_ID |
| D014769 | MESH_DESCRIPTOR_UI |
| DB11476 | DRUGBANK_ID |
| 1269 | INN_ID |
| C49WS9N75L | UNII |
| 127053480 | PUBCHEM_CID |
| 11232 | RXNORM |
| 005455 | NDDF |
| 373554000 | SNOMEDCT_US |
| 420946006 | SNOMEDCT_US |
| 96023008 | SNOMEDCT_US |
| D025761 | MESH_DESCRIPTOR_UI |
| D025762 | MESH_DESCRIPTOR_UI |
| 2192 | INN_ID |
None